NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EValuate Diagnostics, Inc.

EValuate Diagnostics, Inc.

Private
Edison, New JerseyHealthcare & Life Scienceshttps://evaluatediagnostics.com/

Last Round

Seed

Feb 8, 2024

Total Funding Raised

$1M

Company Overview

EValuate Diagnostics, Inc. is a biotechnology company that develops a diagnostic platform for the targeted capture of circulating biomarkers, such as extracellular vesicles, to enable the early detection of tumors and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

liquid biopsyextracellular vesiclesEVsin vitro diagnosticsIVDcompanion diagnosticsCDxbiomarker discoverycancer diagnosticsnon-invasive testingmolecular diagnosticsearly cancer detectionbiotech startupprecision medicinenext-generation sequencingNGS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EValuate Diagnostics, Inc. Comparables

Compare EValuate Diagnostics, Inc. with similar companies based on industry and business-model similarity.

EValuate Diagnostics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mercy BioAnalytics
81%
Mursla Bio
81%
Exosomics S.p.A.
80%

EValuate Diagnostics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 8, 2024

EValuate Diagnostics, Inc. Investors

Notable investors and investment history

EValuate Diagnostics, Inc. investors
InvestorRounds
Hackensack Meridian HealthSeed
Foundation Venture Capital GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 8, 2024

    $1M round led by Foundation Venture Capital Group

EValuate Diagnostics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EValuate Diagnostics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EValuate Diagnostics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersEdison, New Jersey
Employee Range3
Year Founded2023
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.